Yonghua Ling

777 total citations
20 papers, 604 citations indexed

About

Yonghua Ling is a scholar working on Molecular Biology, Genetics and Hematology. According to data from OpenAlex, Yonghua Ling has authored 20 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 5 papers in Genetics and 5 papers in Hematology. Recurrent topics in Yonghua Ling's work include Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Yonghua Ling is often cited by papers focused on Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers) and Epigenetics and DNA Methylation (3 papers). Yonghua Ling collaborates with scholars based in United States, Cambodia and France. Yonghua Ling's co-authors include Kenneth K. Chan, Zhongfa Liu, Joseph M. Covey, Pramod Terse, Yogen Saunthararajah, Kory J. Engelke, U.V.R. Vijaya Saradhi, Reda Z. Mahfouz, Mitch A. Phelps and Susan R. Mallery and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Clinical Cancer Research.

In The Last Decade

Yonghua Ling

20 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yonghua Ling United States	13	307	115	112	87	79	20	604
James M. Pauff United States	12	397 1.3×	146 1.3×	65 0.6×	102 1.2×	53 0.7×	24	841
Sherif Abdelhamed United States	16	522 1.7×	166 1.4×	137 1.2×	55 0.6×	29 0.4×	33	889
Senthilnathan Palaniyandi United States	16	272 0.9×	129 1.1×	138 1.2×	54 0.6×	32 0.4×	32	707
Raffaella Franca Italy	15	273 0.9×	99 0.9×	44 0.4×	62 0.7×	69 0.9×	45	697
Claudia Gemetzi Greece	8	201 0.7×	130 1.1×	67 0.6×	74 0.9×	188 2.4×	11	736
S. Bussa Italy	10	133 0.4×	168 1.5×	113 1.0×	53 0.6×	46 0.6×	17	469
Soumyasri Das Gupta United States	12	360 1.2×	169 1.5×	105 0.9×	32 0.4×	102 1.3×	14	707
Muhammad Farid Johan Malaysia	14	277 0.9×	86 0.7×	186 1.7×	135 1.6×	9 0.1×	55	675
Maria Meli Italy	12	421 1.4×	182 1.6×	35 0.3×	21 0.2×	33 0.4×	34	839
Muhammad Kashif Pakistan	9	463 1.5×	98 0.9×	31 0.3×	16 0.2×	27 0.3×	42	715

Countries citing papers authored by Yonghua Ling

Since Specialization

Citations

This map shows the geographic impact of Yonghua Ling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yonghua Ling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yonghua Ling more than expected).

Fields of papers citing papers by Yonghua Ling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yonghua Ling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yonghua Ling. The network helps show where Yonghua Ling may publish in the future.

Co-authorship network of co-authors of Yonghua Ling

This figure shows the co-authorship network connecting the top 25 collaborators of Yonghua Ling. A scholar is included among the top collaborators of Yonghua Ling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yonghua Ling. Yonghua Ling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sardesai, Sagar, Mohamed Badawi, Ewa Mrózek, et al.. (2020). A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancer. Investigational New Drugs. 38(5). 1400–1410. 24 indexed citations

Yin, Feng, et al.. (2020). Quantitation of uridine and L-dihydroorotic acid in human plasma by LC–MS/MS using a surrogate matrix approach. Journal of Pharmaceutical and Biomedical Analysis. 192. 113669–113669. 19 indexed citations

Yin, Feng, Yonghua Ling, Jennifer M. Keller, et al.. (2020). Quantitation of 2-Hydroxyglutarate in Human Plasma Via LC–MS/MS Using a Surrogate Analyte Approach. Bioanalysis. 12(16). 1149–1159. 10 indexed citations

Chi, Jingduan, et al.. (2017). Quantitation of levodopa and carbidopa in rat plasma by LC–MS/MS: The key role of ion-pairing reversed-phase chromatography. Journal of Chromatography B. 1054. 1–9. 21 indexed citations

Awan, Farrukh T., Joseph M. Flynn, Jeffrey A. Jones, et al.. (2015). Phase I dose escalation trial of the novel proteasome inhibitor carfilzomib in patients with relapsed chronic lymphocytic leukemia and small lymphocytic lymphoma. Leukemia & lymphoma. 56(10). 2834–2840. 12 indexed citations

Terse, Pramod, Kory J. Engelke, Kenneth K. Chan, et al.. (2014). Subchronic Oral Toxicity Study of Decitabine in Combination With Tetrahydrouridine in CD-1 Mice. International Journal of Toxicology. 33(2). 75–85. 10 indexed citations

Pollyea, Daniel A., Steven Coutré, Lia Gore, et al.. (2014). A Dose Escalation Study of Ibrutinib with Lenalidomide for Relapsed and Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Blood. 124(21). 1987–1987. 15 indexed citations

Mahfouz, Reda Z., Ania Jankowska, Quteba Ebrahem, et al.. (2013). Increased CDA Expression/Activity in Males Contributes to Decreased Cytidine Analog Half-Life and Likely Contributes to Worse Outcomes with 5-Azacytidine or Decitabine Therapy. Clinical Cancer Research. 19(4). 938–948. 105 indexed citations

Stephens, Deborah M., Amy S. Ruppert, Kami J. Maddocks, et al.. (2013). Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemia. Leukemia Research. 37(10). 1195–1199. 24 indexed citations

10.

Liu, Ta-Ming, Yonghua Ling, Mitch A. Phelps, et al.. (2013). OSU-T315, An Integrin-Linked Kinase (ILK) Inhibitor, Induces Apoptosis By Targeting B Cell Receptor and CD49d Mediated AKT/ERK Activation In Chronic Lymphocytic Leukemia Cells. Blood. 122(21). 2523–2523. 2 indexed citations

11.

Fan‐Havard, Patty, Zhongfa Liu, Monidarin Chou, et al.. (2013). Pharmacokinetics of Phase I Nevirapine Metabolites following a Single Dose and at Steady State. Antimicrobial Agents and Chemotherapy. 57(5). 2154–2160. 27 indexed citations

12.

Mrózek, Ewa, Robert Wesolowski, Maryam B. Lustberg, et al.. (2013). A phase I study of neoadjuvant chemotherapy (NCT) with the gamma secretase (GS) inhibitor RO4929097 in combination with paclitaxel (P) and carboplatin (C) in women with triple-negative breast cancer (TNBC).. Journal of Clinical Oncology. 31(15_suppl). 1043–1043. 3 indexed citations

13.

He, Lei, J.C. Grecula, Yonghua Ling, et al.. (2012). Development and validation of sensitive liquid chromatography/tandem mass spectrometry method for quantification of bendamustine in mouse brain tissue. Journal of Chromatography B. 905. 141–144. 12 indexed citations

14.

Mortazavi, Amir, Yonghua Ling, Ludmila Katherine Martin, et al.. (2012). A phase I study of prolonged infusion of triapine in combination with fixed dose rate gemcitabine in patients with advanced solid tumors. Investigational New Drugs. 31(3). 685–695. 26 indexed citations

15.

Mallery, Susan R., Ping Pei, Meng Tong, et al.. (2011). Effects of Human Oral Mucosal Tissue, Saliva, and Oral Microflora on Intraoral Metabolism and Bioactivation of Black Raspberry Anthocyanins. Cancer Prevention Research. 4(8). 1209–1221. 90 indexed citations

16.

Lavelle, Donald, Kestis Vaitkus, Yonghua Ling, et al.. (2011). Effects of tetrahydrouridine on pharmacokinetics and pharmacodynamics of oral decitabine. Blood. 119(5). 1240–1247. 72 indexed citations

17.

Saradhi, U.V.R. Vijaya, Sneha Gupta, Ming Chiu, et al.. (2011). Characterization of Silvestrol Pharmacokinetics in Mice Using Liquid Chromatography–Tandem Mass Spectrometry. The AAPS Journal. 13(3). 347–56. 45 indexed citations

18.

Saradhi, U.V.R. Vijaya, Yonghua Ling, Jiang Wang, et al.. (2010). A liquid chromatography–tandem mass spectrometric method for quantification of curcuminoids in cell medium and mouse plasma. Journal of Chromatography B. 878(30). 3045–3051. 50 indexed citations

19.

Ling, Yonghua, Chen Ren, Susan R. Mallery, et al.. (2009). A rapid and sensitive LC–MS/MS method for quantification of four anthocyanins and its application in a clinical pharmacology study of a bioadhesive black raspberry gel. Journal of Chromatography B. 877(31). 4027–4034. 26 indexed citations

20.

Ren, Chen, Patty Fan‐Havard, Natalia Schlabritz‐Loutsevitch, et al.. (2009). A sensitive and specific liquid chromatography/tandem mass spectrometry method for quantification of nevirapine and its five metabolites and their pharmacokinetics in baboons. Biomedical Chromatography. 24(7). 717–726. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact